Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Sevoflurane MACbar in Children
NCT02261675Completed
- Start
- Jan 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Randomised trial of dexmedetomidine (3 arms). Primary endpoint: Minimum Alveolar Concentration Blocking Adrenergic Response. Started Jan 2013; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT02261675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261675.